OA19.04LB Silk fibroin as a mucosal delivery vehicle for Griffithsin and antiviral compounds: effective protection of macaques and high acceptance among user groupsOral Abstract SessionDelivery technologies: novel approaches, formulation and multi-purpose
OA19.05LB Pharmacokinetic and pharmacodynamic study of tenofovir and tenofovir alafenamide for PrEP in foreskin tissueOral Abstract SessionPharmacology/PK and PD studies
OA20.01 Alternative T cell effector functions are linked to humoral responses to HIV infectionOral Abstract SessionCellular immunity
OA20.02 HIV-resistant dual CD28/4-1BB costimulated CAR T cells mitigate HIV pathogenesis in humanized miceOral Abstract SessionCellular immunity
OA20.03 Immune perturbation is more profound in newborn than in infant macaques during acute SHIV infectionOral Abstract SessionPreclinical studies for HIV prevention
OA20.04 Tissue-resident memory CD4+ T cells in ectocervical versus endocervical specimensOral Abstract SessionMucosal immunity
OA20.05 HIV-1 infection and the control of viral replication are associated with greater expression of interleukin-21 receptor on CD8+ T cellsOral Abstract SessionCellular immunity
OA21.01 Effect of navigation services to achieve viral suppression among men who have sex with men (MSM) and transwomen living with HIV who attend public HIV care services in Lima, PeruOral Abstract SessionImplementation science, including structural interventions, PrEP & VMMC
OA21.02 Methadone program participation and current ART use among people who inject drugs in KenyaOral Abstract SessionDiscovery and evaluation of biomedical agents
OA21.03 Using an HIV risk assessment tool to increase frequency of HIV testing in men who have sex with men in Beijing, China: an app-based randomized, controlled trialOral Abstract SessionClinical trial results
seek-warrow-warrow-eseek-e171 - 180 of 444 items